2004 Annual Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
UCB SA (Incorporated with Limited Liability in Belgium) As Issuer
Base Prospectus dated 8 March 2021 UCB SA (incorporated with limited liability in Belgium) as Issuer EUR 5,000,000,000 Euro Medium Term Note Programme Due from one month from the date of original issue This base prospectus (the “Base Prospectus”) relating to the EUR 5,000,000,000 Euro Medium Term Note Programme (the “Programme”) of UCB SA, a limited liability company (société anonyme) incorporated under the laws of Belgium, having its registered office at Allée de la Recherche 60, B-1070 Brussels and registered with the Crossroads Bank for Enterprises under number 0403.053.608 (“UCB”, or the “Issuer”) is valid, for the purpose of the admission to trading and listing of the Notes (as defined below) on the regulated market of Euronext Brussels or on another regulated market in the European Economic Area (the “EEA”), for a period of twelve months from the date of approval. Any Notes issued under the Programme are issued subject to the provisions set out herein. Under the Programme, the Issuer, subject to compliance with all relevant laws, regulations and directives, may from time to time issue Euro Medium Term Notes (the “Notes”) as may be agreed between the Issuer and the relevant Dealer (as defined below). The minimum Specified Denomination of Notes shall be EUR 100,000 (or its equivalent in other currencies).The maximum aggregate nominal amount of Notes outstanding will not at any time exceed EUR 5,000,000,000 (or the equivalent in other currencies). This Base Prospectus has been approved as a base prospectus for the purposes of Article 8 of Regulation 2017/1129 (as amended, the “Prospectus Regulation”) on 8 March 2021 by the Belgian Financial Services and Markets Authority (the “FSMA”) in its capacity as competent authority in accordance with Article 20 of the Prospectus Regulation. -
Stronger Together Annual Report 2007/ 08 the NA Group
Stronger together Annual Report 2007/ 08 The NA Group Norddeutsche Affi nerie is the leading integrated copper group in Europe. Our core competence lies in the production and processing of copper, the material of the future. We are excellently represented all along the value added chain of copper from raw material processing and cathode production through to the production of copper products. We are also outstandingly positioned worldwide in the recycling of copper and other metals. Copper Production Copper Processing Cathodes, precious Shapes, wire rod, wires, metals and by-products strips and profi les In the Copper Production Segment we produce As an integrated copper group, we process our copper copper cathodes from copper concentrates and recy- cathodes into a variety of copper products, fi rst and cled raw materials. Both types of raw materials are foremost electrolytic copper wire rod for the cable and sourced internationally; recycled raw materials are wire industry. In addition, we produce continuous also procured in Germany. Our earnings are primarily cast shapes from cathodes for the market and for pro- determined by treatment and refi ning charges that cessing internally into pre-rolled strip as well as strips, are agreed with the raw material suppliers as the pro- shaped wires and profi les. Our revenues are deter- cessing fee. Our copper cathodes fulfi l the very high mined inter alia by processing fees that refl ect the quality requirements of the metal exchanges. The value added. Copper Production Segment also includes the produc- tion of precious metals, sulphuric acid, iron silicate products and other metal and chemical products from the by-elements of copper in the raw materials. -
Integrated Annual Report 2020
Amber, living with psoriasis INTEGRATED ANNUAL REPORT 2020 ADAPTING FOR BETTER CARE INTEGRATED ANNUAL REPORT 2020 ADAPTING FOR BETTER CARE Welcome to our Integrated Annual Report 2020! Our Integrated Annual Report 2020 – Adapting for Better Care – aims to provide all interested stakeholders with the best pos- sible information on how UCB is creating value for patients with severe diseases and about how we care for our employees, for communities, and for our planet, now and into the future. About this report This Integrated Annual Report 2020 includes the management report in accordance with article 12 of the Royal Decree of 14 November 2007 relating to the obligations of issuers of finan- cial instruments admitted to trading on a regulated market. All information required to be included in such management report pursuant to articles 3:6 and 3:32 of the Belgian Code of Com- panies and Associations (i.e. Corporate Governance Statement – Remuneration Report included -, Business Performance Review and UCB’s Statement on extra-financial1 information) is reported throughout all different sections of this Integrated Annual Re- port. This Integrated Annual Report together with the materiality assessment have been prepared in accordance with the Global Reporting Standards core option and extra-financial information is audited by a third party. 1 ‘Extra-financial’ is the term used by UCB for information commonly referred to as ‘non-financial’. UCB | Integrated Annual Report 2020 3 Index Key Figures 6 UCB At a Glance 8 Letter to our stakeholders -
September 2020 Introduction to Umicore We Are a Global Materials Technology and Recycling Group
Umicore Investor Presentation September 2020 Introduction to Umicore We are a global materials technology and recycling group One of three global A leading supplier of key The world’s leading leaders in emission control materials for rechargeable recycler of complex waste catalysts for light-duty and batteries used in electrified streams containing heavy-duty vehicles and transportation and portable precious and other for all fuel types electronics valuable metals 3 With a unique position in clean mobility materials and recycling Internal Plug-In Hybrid Combustion Engine Electric Vehicle Umicore provides: Umicore provides: Emission control catalysts Battery cathode materials and emission control catalysts Full Electric Vehicle Fuel cells Umicore provides: Umicore provides: Battery cathode materials Electro-catalyst and battery cathode materials Present across all drive trains and offering sustainable closed- loop services 4 Built on sound foundations Supportive Unique business Industry leader in megatrends & model sustainability legislation resource scarcity more stringent emission control electrification recyclingrecycling of the automobile We help improve air quality, make electrified transport possible and tackle resource scarcity 5 5 With a robust financial performance and a global presence Key figures (FY 2019) Adj. Revenues EBITDA € 3.4 bn € 753 m Adj. EBIT ROCE € 509 m 12.6% 40% - Europe Revenues* by Clean geography 14% - North America mobility and R&D Recycling 6% of 4% - South America 75% of revenues revenues 39% - Asia-Pacific -
Belgium Division of Operational Services Sources: UNHCR Regional Office UNHCR, Global Insight Digital Mapping © 1998 Europa Technologies Ltd
FF II CC SS SS Field Information and Coordination Support Section Capital Belgium Division of Operational Services Sources: UNHCR Regional office UNHCR, Global Insight digital mapping © 1998 Europa Technologies Ltd. As of July 2008 International boundary The boundaries and names shown Main road and the designations used on this map do not imply official endorsement or acceptance by the United Nations. Secondary road Name_of_the_workspace.WOR !! j !! !! Roosendaal !! !! !! !! !! Venray !! Geldern !! Bottrop !! Best !! Middelburg !! Goes !! Kamp Lintfort !! !! Bergen op Zoom Railway!! !! !! Duisburg !! Helmond !! !! !! Oberhausen !! Essen !! Moers-VinnMoers !! !! Vlissingen !! !! !! !! Kerken !! Eindhoven !! !! Elevation !! Mulheim !! Wuustwezel NETHERLANDSNETHERLANDS!! !! NETHERLANDSNETHERLANDS!! NETHERLANDSNETHERLANDS!! !! Margate North Sea !! !! Venlo !! !! Kempen !! Valkenswaard !! Knokke-Heist !! !! (Above mean sea level) !! !! Ramsgate !! Brecht !! Krefeld !! Ve !! !! Turnhout !! !! !! Terneuzen !! !! !! !! Blankenberge Kapellen !! Nettetal !! !! 3,250 to 4,000 metres !! Arendonk !! !! !! Schoten !! Weert !! Viersen !! !! Düsseldorf !! !! Zelzate 2,500 to 3,250!! metres !! Oostende!! !! !! !! Deal !! !! St-Gillis-Waas !! Zandhoven !! Brugge!! Maldegem !! AntwerpenAntwerp !! !! !! !! !! Roermond!! !! Middelkerke !! !! !! Mol !! MonchenMonchengladbach Gladbach !! !! !! !! !! Herentals !! 1,750 to 2,500 metres !! !! Jabbeke !! St Niklaas!! !! !! Hilden!! S !! !! !! Balen !! !! !! !! Rheydt !! Neuss Beernem !! Bree !! Zedelgem!! !! -
Antwerpen, Belgium
10th European Congress on Tropical Medicine and International Health Antwerpen, Belgium Preliminary Programme www.ECTMIH2017.be Table of Contents Legend ....................................................................................................... 4 Programme Monday Opening Ceremony ................................................................. 7 Tuesday Programme at a Glance .......................................................... 8 Programme S and OS ............................................................. 10 Wednesday Programme at a Glance .......................................................... 28 Programme S and OS ............................................................. 30 Thursday Programme at a Glance .......................................................... 44 Programme S and OS ............................................................. 46 Friday Programme at a Glance .......................................................... 65 Programme S and OS ............................................................. 66 Posters Poster List Tuesday............................................................................ 71 Poster List Wednesday ...................................................................... 92 Poster List Thursday .......................................................................... 114 2 www.ectmih2017.be www.ectmih2017.be 3 Legend Colour Codes The programme is organised in 8 tracks. These 8 tracks are listed on page 5. Track 1. Breakthroughs and innovations in tropical biomedical -
Umicore Intends to Launch Squeeze-Out for Remainder of Agosi
Press release 3 February 2021 – 08:30 am CET Umicore intends to launch squeeze-out for remainder of Agosi shares Umicore has informed its listed subsidiary Allgemeine Gold- und Silberscheideanstalt AG (“Agosi”) that it intends to purchase the 8.8 % shares it does not yet own from Agosi’s minority shareholders through a merger squeeze-out in accordance with German law. To determine the cash compensation for Agosi’s minority shareholders, a valuation of Agosi will be carried out by an independent valuer appointed by Umicore and a court-appointed auditor. Following a squeeze-out and subsequent delisting, Umicore would have flexibility to consider strategic options for the Jewelry & Industrial Metals activities within Agosi. These activities perform well from a commercial and financial point of view and Umicore wants to explore the best conditions for their further development. Umicore expects that the merger squeeze-out would be resolved upon by the general meeting of Agosi in the second or third quarter of 2021. Note to the editor: Umicore acquired Agosi upon the acquisition of the Precious Metals Group (“PMG”) in 2003 and currently holds 91.2 % of its shares. Agosi shares are listed on the Munich Freiverkehr stock exchange. Agosi, headquartered in Pforzheim, Germany, has an international presence and offers the full precious metals cycle and other precious metals services for the jewelry and coin industries, as well as for various industrial applications in electrical engineering, in automotive, in the chemical industry and in medical technology. Agosi’s activities are integrated in Umicore’s Jewelry & Industrial Metals business unit and one Agosi subsidiary is part of Umicore’s Electroplating business unit. -
The Mineral Industry of Belgium in 2016
2016 Minerals Yearbook BELGIUM [ADVANCE RELEASE] U.S. Department of the Interior October 2019 U.S. Geological Survey The Mineral Industry of Belgium By Sinan Hastorun The mineral industry in Belgium was primarily a Government Policies and Programs manufacturer and processor of metals, having largely transitioned away from mining minerals. As there was no No national mining law was in place in Belgium. The extraction of metal ores in the country, raw materials for its management of mineral resources, with the exception of those metal refining industry were sourced from imports or secondary on the continental shelf in the North Sea, was the responsibility scrap. In 2016, Belgium was the world’s 4th-ranked selenium of the three geographic regions of Belgium: Flanders, Wallonia, producer (excluding the United States), 5th-ranked arsenic and the Brussels capital region. The central Government was and indium producer, and 20th-ranked (tied with the United responsible for the security of the energy supply and nuclear Kingdom) lime producer. The country accounted for 6% of the energy, whereas the regional Governments were responsible world’s selenium output, and 3% each of the world’s output of for overseeing the distribution of natural gas and electricity arsenic and indium. Within the European Union (EU), Belgium conducted by the private sector. The legal regulations governing was a significant processor of cobalt, primary and secondary primary industrial mineral resources and extraction activities copper, lead, pig iron, steel, and zinc. For the United States, were as follows: In Flanders, the Flemish Parliament Act on Belgium was an important import source of antimony, bismuth, Surface Mineral Resources provides the legislative framework gemstones, germanium, mica, rhenium, and tellurium. -
Euro Stoxx® Multi Premia Index
EURO STOXX® MULTI PREMIA INDEX Components1 Company Supersector Country Weight (%) SARTORIUS STEDIM BIOTECH Health Care France 1.59 IMCD Chemicals Netherlands 1.25 VOPAK Industrial Goods & Services Netherlands 1.15 BIOMERIEUX Health Care France 1.04 REMY COINTREAU Food, Beverage & Tobacco France 1.03 EURONEXT Financial Services France 1.00 HERMES INTERNATIONAL Consumer Products & Services France 0.94 SUEZ ENVIRONNEMENT Utilities France 0.94 BRENNTAG Chemicals Germany 0.93 ENAGAS Energy Spain 0.90 ILIAD Telecommunications France 0.89 DEUTSCHE POST Industrial Goods & Services Germany 0.88 FUCHS PETROLUB PREF Chemicals Germany 0.88 SEB Consumer Products & Services France 0.87 SIGNIFY Construction & Materials Netherlands 0.86 CARL ZEISS MEDITEC Health Care Germany 0.80 SOFINA Financial Services Belgium 0.80 EUROFINS SCIENTIFIC Health Care France 0.80 RATIONAL Industrial Goods & Services Germany 0.80 AALBERTS Industrial Goods & Services Netherlands 0.74 KINGSPAN GRP Construction & Materials Ireland 0.73 GERRESHEIMER Health Care Germany 0.72 GLANBIA Food, Beverage & Tobacco Ireland 0.71 PUBLICIS GRP Media France 0.70 UNITED INTERNET Technology Germany 0.70 L'OREAL Consumer Products & Services France 0.70 KPN Telecommunications Netherlands 0.68 SARTORIUS PREF. Health Care Germany 0.68 BMW Automobiles & Parts Germany 0.68 VISCOFAN Food, Beverage & Tobacco Spain 0.67 SAINT GOBAIN Construction & Materials France 0.67 CORBION Food, Beverage & Tobacco Netherlands 0.66 DAIMLER Automobiles & Parts Germany 0.66 PROSIEBENSAT.1 MEDIA Media Germany 0.65 -
2016 Dec Patricio Barrios RESUME
December 2016 RESUME – P. Barrios RESUME EDUCATION: BSc. Chemistry - University Seville, Spain MSc. Chemical Engineering - University Seville, Spain PhD. Chemistry - University Seville, Spain; Thesis: “Kinetics of the Copper Blow Stage during pyrometallurgical Copper-Making” (A Kinetic Model) Dipl. Environmental Eng. - Technical University Madrid, Spain Dipl. R&D Management - CSIC (High Counsel Scientist Research) Madrid, Spain Dipl. Business Administration -ESADE Barcelona, Spain, and The International Social Science Council Paris, France PROFESIONAL EXPERIENCE: January 2016 – Present: Aurubis AG; Principal Adviser – Primary Copper. Responsible to provide high level strategic advice to the EVP-Primary Copper BU which includes assisting on the overall direction and function of Business Development, participating on special projects, including liaison and development of key relationships with selected business partners. April 2008 – December 2015: Aurubis AG (new public company resulting from the merging of Cumerio and Norddeutsche Affinerie ,with operations and activities in 22 countries around Europe, North America and Asia, totaling 6400 employees and 13.8 Billion € revenues): Senior Vice President - Projects Primary Copper. Responsible for Primary Copper Business Unit’s growing projects, with main focus on new business opportunities and external projects. April 2006 – April 2008: Cumerio (public Belgian company resulting from the carve-out of the former Union Miniere’s Copper operations): Vice President Operations & ExCom Member. Full corporate responsibility for the Cumerio Group operations: Copper Refining BU and Copper Products BU with operations in Pirdop (Bulgaria), Olen (Belgium) and Avellino (Italy); totaling 1500 employees and 3.5 Billion € of revenues. 2005 – March 2006: Associated, as Senior Adviser- Non Ferrous Metals at Hatch Corporate Finance (HCF) International Advisers (formerly HB Advisers) –Hatch Group-; a London based leading corporate finance advisory firm focused exclusively on the metals and mining sectors worldwide. -
Carte Du Reseau Netkaart
AMSTERDAM ROTTERDAM ROTTERDAM ROOSENDAAL Essen 4 ESSEN Hoogstraten Baarle-Hertog I-AM.A22 12 ANTWERPEN Ravels -OOST Wildert Kalmthout KALMTHOUT Wuustwezel Kijkuit Merksplas NOORDERKEMPEN Rijkevorsel HEIDE Zweedse I-AM.A21 ANTW. Kapellen Kaai KNOKKE AREA Turnhout Zeebrugge-Strand 51A/1 202 Duinbergen -NOORD Arendonk ZEEBRUGGE-VORMING HEIST 12 TURNHOUT ZEEBRUGGE-DORP TERNEUZEN Brasschaat Brecht North-East BLANKENBERGE 51A 51B Knokke-Heist KAPELLEN Zwankendamme Oud-Turnhout Blankenberge Lissewege Vosselaar 51 202B Beerse EINDHOVEN Y. Ter Doest Y. Eivoorde Y.. Pelikaan Sint-Laureins Retie Y. Blauwe Toren 4 Malle Hamont-Achel Y. Dudzele 29 De Haan Schoten Schilde Zoersel CARTE DU RESEAU Zuienkerke Hamont Y. Blauwe Toren Damme VENLO Bredene I-AM.A32 Lille Kasterlee Dessel Lommel-Maatheide Neerpelt 19 Tielen Budel WEERT 51 GENT- Wijnegem I-AM.A23 Overpelt OOSTENDE 50F 202A 273 Lommel SAS-VAN-GENT Sint-Gillis-Waas MECHELEN NEERPELT Brugge-Sint-Pieters ZEEHAVEN LOMMEL Overpelt ROERMOND Stekene Mol Oostende ANTWERPEN Zandhoven Vorselaar 50A Eeklo Zelzate 19 Overpelt- NETKAART Wommelgem Kaprijke Assenede ZELZATE Herentals MOL Bocholt BRUGGE Borsbeek Grobbendonk Y. Kruisberg BALEN- Werkplaatsen Oudenburg Jabbeke Wachtebeke Moerbeke Ranst 50A/5 Maldegem EEKLO HERENTALS kp. 40.620 WERKPLAATSEN Brugge kp. 7.740 Olen Gent Boechout Wolfstee 15 GEEL Y. Oostkamp Waarschoot SINT-NIKLAAS Bouwel Balen I-AM.A34 Boechout NIJLEN Y. Albertkanaal Kinrooi Middelkerke OOSTKAMP Evergem GENT-NOORD Sint-Niklaas 58 15 Kessel Olen Geel 15 Gistel Waarschoot 55 219 15 Balen BRUGGE 204 Belsele 59 Hove Hechtel-Eksel Bree Beernem Sinaai LIER Nijlen Herenthout Peer Nieuwpoort Y. Nazareth Ichtegem Zedelgem BEERNEM Knesselare Y. Lint ZEDELGEM Zomergem 207 Meerhout Schelle Aartselaar Lint Koksijde Oostkamp Waasmunster Temse TEMSE Schelle KONTICH-LINT Y. -
Dynavax Announces Full Enrollment of Phase II/III AIC Trial
Dynavax Announces Full Enrollment of Phase II/III AIC Trial BERKELEY, Calif., May 19 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases, today announced that its Phase II/III clinical trial of AIC for ragweed allergy, which started in late February 2004, has been fully enrolled. The double blind, placebo controlled study involves 462 subjects at 30 sites in the U.S. and will be completed over the next 18 months. The immunization schedule, consisting of six injections over six weeks, will be completed by June. The clinical trial is being conducted in collaboration with UCB Pharma, a European pharmaceutical company that markets XYZAL® and developed ZYRTEC®, the leading prescription anti- allergy drug worldwide. Dynavax and UCB signed a global licensing and commercialization agreement covering ragweed and grass allergy immunotherapies in February 2004. The primary endpoint of the Phase II/III ragweed study will be nasal symptoms scores after the second ragweed season in the late summer and early fall of 2005, with secondary endpoints assessing symptoms, medication use and quality of life in both the first and second year. A blinded interim analysis will be made in late 2004 to assess safety and the appropriateness of commencing a one-year Phase III trial in early 2005. "The collaboration with UCB has been very effective, with both organizations working diligently to advance our ragweed program," said Dr. Dino Dina, president and CEO of Dynavax. "The rapid enrollment of our ragweed trial, particularly given its size and stringent enrollment criteria, is an early indication of the level of interest that both investigators and patients have in this therapy.